ethacrynate sodium
Generic: ethacrynate sodium
Labeler: leading pharma, llcDrug Facts
Product Profile
Brand Name
ethacrynate sodium
Generic Name
ethacrynate sodium
Labeler
leading pharma, llc
Dosage Form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes
Active Ingredients
ethacrynate sodium 50 mg/50mL
Manufacturer
Identifiers & Regulatory
Product NDC
69315-701
Product ID
69315-701_f2c45a04-b3df-48cd-93e2-edb917a029cf
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA208663
Listing Expiration
2027-12-31
Marketing Start
2026-01-09
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
69315701
Hyphenated Format
69315-701
Supplemental Identifiers
RxCUI
UPC
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
ethacrynate sodium (source: ndc)
Generic Name
ethacrynate sodium (source: ndc)
Application Number
ANDA208663 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 50 mg/50mL
Packaging
- 1 VIAL, SINGLE-DOSE in 1 CARTON (69315-701-50) / 50 mL in 1 VIAL, SINGLE-DOSE
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS"], "spl_id": "f2c45a04-b3df-48cd-93e2-edb917a029cf", "openfda": {"upc": ["0369315701508"], "unii": ["K41MYV7MPM"], "rxcui": ["617325"], "spl_set_id": ["e24e7440-a958-6fd0-6bfe-1bd29e638657"], "manufacturer_name": ["Leading Pharma, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (69315-701-50) / 50 mL in 1 VIAL, SINGLE-DOSE", "package_ndc": "69315-701-50", "marketing_start_date": "20260109"}], "brand_name": "ETHACRYNATE SODIUM", "product_id": "69315-701_f2c45a04-b3df-48cd-93e2-edb917a029cf", "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION", "pharm_class": ["Increased Diuresis at Loop of Henle [PE]", "Loop Diuretic [EPC]"], "product_ndc": "69315-701", "generic_name": "ETHACRYNATE SODIUM", "labeler_name": "Leading Pharma, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "ETHACRYNATE SODIUM", "active_ingredients": [{"name": "ETHACRYNATE SODIUM", "strength": "50 mg/50mL"}], "application_number": "ANDA208663", "marketing_category": "ANDA", "marketing_start_date": "20260109", "listing_expiration_date": "20271231"}